Synthesis and Structural Study of Amidrazone Derived Pyrrole-2,5-Dione Derivatives: Potential Anti-Inflammatory Agents. 2022

Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasza Str. 2, 85-089 Bydgoszcz, Poland.

1H-pyrrole-2,5-dione derivatives are known for their wide range of pharmacological properties, including anti-inflammatory and antimicrobial activities. This study aimed to synthesize new 3,4-dimethyl-1H-pyrrole-2,5-dione derivatives 2a-2f in the reaction of N3-substituted amidrazones with 2,3-dimethylmaleic anhydride and evaluate their structural and biological properties. Compounds 2a-2f were studied by the 1H-13C NMR two-dimensional techniques (HMQC, HMBC) and single-crystal X-ray diffraction (derivatives 2a and 2d). The anti-inflammatory activity of compounds 2a-2f was examined by both an anti-proliferative study and a production study on the inhibition of pro-inflammatory cytokines (IL-6 and TNF-α) in anti-CD3 antibody- or lipopolysaccharide-stimulated human peripheral blood mononuclear cell (PBMC) cultures. The antibacterial activity of compounds 2a-2f against Staphylococcus aureus, Enterococcus faecalis, Micrococcus luteus, Esherichia coli, Pseudomonas aeruginosa, Yersinia enterocolitica, Mycobacterium smegmatis and Nocardia corralina strains was determined using the broth microdilution method. Structural studies of 2a-2f revealed the presence of distinct Z and E stereoisomers in the solid state and the solution. All compounds significantly inhibited the proliferation of PBMCs in anti-CD3-stimulated cultures. The strongest effect was observed for derivatives 2a-2d. The strongest inhibition of pro-inflammatory cytokine production was observed for the most promising anti-inflammatory compound 2a.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.

Related Publications

Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
January 2010, Bioorganic & medicinal chemistry letters,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
March 2004, Bioorganic & medicinal chemistry,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
January 2020, European journal of medicinal chemistry,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
April 1995, Drug design and discovery,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
August 2004, Bioorganic & medicinal chemistry letters,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
May 2013, European journal of medicinal chemistry,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
January 2006, Arzneimittel-Forschung,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
April 2007, Acta crystallographica. Section C, Crystal structure communications,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
February 2005, The Journal of pharmacy and pharmacology,
Renata Paprocka, and Leszek Pazderski, and Liliana Mazur, and Małgorzata Wiese-Szadkowska, and Jolanta Kutkowska, and Michalina Nowak, and Anna Helmin-Basa
June 2022, Molecules (Basel, Switzerland),
Copied contents to your clipboard!